The identification of conduction gaps after pulmonary vein isolation using a new electroanatomic mapping system

Heart Rhythm ◽  
2017 ◽  
Vol 14 (11) ◽  
pp. 1606-1614 ◽  
Author(s):  
Masaharu Masuda ◽  
Masashi Fujita ◽  
Osamu Iida ◽  
Shin Okamoto ◽  
Takayuki Ishihara ◽  
...  
EP Europace ◽  
2016 ◽  
Vol 18 (suppl_1) ◽  
pp. i6-i6
Author(s):  
Francesco Santoro ◽  
Ardan Saguner ◽  
Christine Lemes ◽  
Christian Sohns ◽  
Shibu Mathew ◽  
...  

CHEST Journal ◽  
2004 ◽  
Vol 125 (5) ◽  
pp. 1830-1836
Author(s):  
Gil Bolotin ◽  
Frederik H. van der Veen ◽  
Tamir Wolf ◽  
Rona Shofti ◽  
Roberto Lorusso ◽  
...  

2019 ◽  
Vol 40 (Supplement_1) ◽  
Author(s):  
Y Okuyama ◽  
T Ashihara ◽  
T Ozawa ◽  
Y Fujii ◽  
K Kato ◽  
...  

Abstract Introduction It is reported that for patients with non-paroxysmal (persistent or long-standing persistent) atrial fibrillation (Non-PAF), extended ablation to atrial walls in addition to pulmonary vein isolation (PVI) did not improve the long-term outcome. On the other hand, modulation of Non-PAF drivers (or perpetuators) has been proposed as one of the alternative effective ablation strategies for Non-PAF. Purpose To clarify whether the rotor ablation under online real-time high-density phase mapping system is effective for PVI-refractory Non-PAF ablation. Methods Under such circumstances, our academic group had recently developed the online real-time high-density phase mapping system (ExTRa Mapping™) by industrial alliance. The phase map moving images were based on 41 intra-atrial bipolar signals recorded by a 20-pole spiral-shaped catheter (2.5 cm in diameter) and on in silicorapid prediction of spatio-temporal atrial excitations (artificial intelligence system). Then we applied the ExTRa Mapping to clinical practice in order to directly visualize rotors in patients with Non-PAF, and investigated the middle- to long-term outcome of the ExTRa Mapping-guided rotor ablation (ExTRa-ABL). Results Thirty-eight patients (63±8 y/o, 30 males) with Non-PAF demonstrating refractoriness to PVI were enrolled in this study. Ablation for cavo-tricuspid isthmus and/or superior vena cava isolation was additionally performed at physicians' discretion. After these procedures, the ExTRa-ABL was performed in order to modify Non-PAF substrates, causing rotor control. The modification of the rotors was evaluated by re-mapping with the use of the ExTRa Mapping at the end of each ablation session. Patients were followed at 1, 3, 6 months and every year after the procedure. All of them were followed for 21±8 months. During the follow-up period, Non-PAF was recurred in only 8 of 38 (21%). Furthermore, we found if PVI-refractory Non-PAF duration was shorter than 6 years, the non-recurrence rate remained ≥80% (see Figure), which was markedly better outcome comparing with previous reports with regard to Non-PAF ablation. Figure 1 Conclusion Comparing with conventional Non-PAF ablation strategies, our novel approach with the use of the online real-time high-density phase mapping system might improve medium- to long-term outcome of PVI-refractory Non-PAF treatment.


Sign in / Sign up

Export Citation Format

Share Document